Analytical Data
-
基因名
EFNA3
- Application
-
别名
EFNA3；EFL2；EPLG3；LERK3;Ephrin-A3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P52797
-
表达区间
23-211aa
-
氨基酸序列
QGPGGALGNRHAVYWNSSNQHLRREGYTVQVNVNDYLDIYCPHYNSSGVG PGAGPGPGGGAEQYVLYMVSRNGYRTCNASQGFKRWECNRPHAPHSPIKF SEKFQRYSAFSLGYEFHAGHEYYYISTPTHNLHWKCLRMKVFVCCASTSH SGEKPVPTLPQFTMGPNVKINVLEDFEGENPQVPKLEKSVDHHHHHH
-
分子量
22 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human HCRTR2 Protein，His
Cat：PA2000-3724
Recombinant Human EEF2K Protein，His
Cat：PA1000-974DB
Protein Description
EFNA3, or Ephrin-A3, is a crucial member of the ephrin family, which plays a significant role in cell communication, particularly in the development of the nervous system. It interacts with Eph receptors, facilitating bidirectional signaling that influences cell adhesion, migration, and survival. This protein is involved in various biological processes, including angiogenesis, neural patterning, and tumor progression. Research has shown that abnormalities in EFNA3 expression are associated with several diseases, including cancers and neurodegenerative disorders. The production of recombinant EFNA3 proteins has facilitated studies into its structure-function relationships, signaling pathways, and potential therapeutic applications. Understanding EFNA3's biological roles could unveil new strategies for targeting diseases where these pathways are dysregulated, making it a focus of current biomedical research. Additionally, the exploration of EFNA3 in the context of tissue engineering, regenerative medicine, and cancer therapeutics continues to demonstrate its potential in novel treatment approaches.
